YCBD - cbdMD Total Debt to Capital

Public company logo of cbdMD Inc. (YCBD)

cbdMD, Inc. (YCBD) is currently struggling with a liquidity shortage due to declining CBD product sales, necessitating cost reductions. Simultaneously, the business is implementing eco-standards by utilizing recyclable packaging and renewable raw materials. The company's price chart reflects a total debt-to-equity ratio of 0.26. Wellness product manufacturing is concentrated in the US, where the company leverages its recognizable brand and online distribution.

YCBD: cbdMD Corp Total Debt to Capital 07/04/2022 - 10/29/2026

Analytical breakdowns for cbdMD, Inc.

- price and consensus price forecast:
Price Chart cbdMD Inc.|YCBD - Forecast Levels Chart
- market capitalization statistics:
Market Capitalization cbdMD|YCBD - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share cbdMD|YCBD - Book Capitalization|Market Value to Book Value Ratio cbdmd.com|YCBD - Aggregate Asset Value
- company total debt and liquidity indicators:
Debt to Equity cbdMD, Inc.|YCBD - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital cbdMD Inc.|YCBD - Company Aggregate Debts|Debt to Book Value cbdMD|YCBD - Company Long-Term Loans and Borrowings|Company Short-Term Debt cbdMD|Quick Liquidity Indicator cbdmd.com
- earnings and valuation multiples information:
YCBD - Profit After Payment of Taxes
Basic company analysis:cbdMD, Inc.
Core merchandise of cbdMD

To filter for high-quality assets, investors evaluate the balance between borrowed and equity funds to determine the stability of the financing structure. This metric measures the proportion of total liabilities to equity, which on the GURU.Markets platform, via the debt-to-equity ratio, demonstrates the dependence of cbdMD, Inc. (YCBD) on loans while scaling CBD product sales amid volatile wellness market legislation.

Competitor analysis for cbdMD, Inc.

Debt to Equity Haleon|Kenvue Inc - Aggregate Debt to Equity|Total Debt to Capital VRNA|MENS (Jyong Bio) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital LGND (Ligand Pharmaceuticals)|Total Debt to Capital amneal.com AMRX|PRGO - Debt to Equity|All Debt to Shareholders' Equity Ratio ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Debt to Equity|Total Debt to Equity Ratio Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital mannkindcorp.com|Total Debt to Equity Ratio AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - All Debt to Shareholders' Equity Ratio|Debt to Equity ARS Pharma SPRY|Theravance Corp (TBPH) - Debt to Capital|AQST: Total Debt to Equity Ratio|scPharmaceuticals Inc. - Aggregate Debt to Capital|TECX: Total Debt to Capital|Tonix Pharma - All Debt to Shareholders' Equity Ratio|SXTC (SXT Pharmaceuticals) - Total Debt to Capital|Debt to Capital Eupraxia Pharma EPRX|Debt to Equity BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital ORMP (Oramed Pharmaceuticals Inc.)|ENTX - Total Debt to Equity Ratio|MindWalk - Total Debt to Capital|ABVC: Debt to Equity|CPIX: Total Debt to Capital|Debt to Equity Ratio QNTM|Debt to Equity FibroGen|Total Debt to Equity Ratio Telomir Pharmaceuticals Inc (TELO)|Total Debt to Capital RANI|synergychc.com - Debt to Equity Ratio|Rallybio - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio LEXX|Pulmatrix - Total Debt to Capital|Total Debt to Capital Coefficient Pheton Holdings Ltd PTHL|aptorumgroup.com (APM) - Debt to Equity|Debt to Equity Ratio LYRA|IBO (Impact BioMedical Inc) - Total Debt to Capital|Total Debt to Equity Ratio TNF Pharma (TNFA)|Total Debt to Equity Ratio PRFX (PainReform)|Total Debt to Capital Coefficient altamiratherapeutics.com|Lipella - Total Debt to Equity Ratio|OptiNose Corp (OPTN) - Debt to Capital|Pieris Pharmaceuticals - Total Debt to Capital|procapsgroup.com (PROC) - Total Debt to Equity Ratio|PTPI: Total Debt to Capital|QLI (Qilian International Holding Group) - Debt to Equity|SLRN (ACELYRIN, Inc.) - Total Debt to Capital|Debt to Equity Ratio TFFP (TFF Pharmaceuticals, Inc)